Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals

Abstract Background Data-sharing policies in randomized clinical trials (RCTs) should have an evaluation component. The main objective of this case–control study was to assess the impact of published re-uses of RCT data in terms of media attention (Altmetric) and citation rates. Methods Re-uses of R...

Full description

Bibliographic Details
Main Authors: N. Anthony, C. Pellen, C. Ohmann, D. Moher, F. Naudet
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Medical Research Methodology
Subjects:
Online Access:https://doi.org/10.1186/s12874-021-01311-z
_version_ 1818932919079534592
author N. Anthony
C. Pellen
C. Ohmann
D. Moher
F. Naudet
author_facet N. Anthony
C. Pellen
C. Ohmann
D. Moher
F. Naudet
author_sort N. Anthony
collection DOAJ
description Abstract Background Data-sharing policies in randomized clinical trials (RCTs) should have an evaluation component. The main objective of this case–control study was to assess the impact of published re-uses of RCT data in terms of media attention (Altmetric) and citation rates. Methods Re-uses of RCT data published up to December 2019 (cases) were searched for by two reviewers on 3 repositories (CSDR, YODA project, and Vivli) and matched to control papers published in the same journal. The Altmetric Attention Score (primary outcome), components of this score (e.g. mention of policy sources, media attention) and the total number of citations were compared between these two groups. Results 89 re-uses were identified: 48 (53.9%) secondary analyses, 34 (38.2%) meta-analyses, 4 (4.5%) methodological analyses and 3 (3.4%) re-analyses. The median (interquartile range) Altmetric Attention Scores were 5.9 (1.3—22.2) for re-use and 2.8 (0.3—12.3) for controls (p = 0.14). No statistical difference was found on any of the components of in the Altmetric Attention Score. The median (interquartile range) numbers of citations were 3 (1—8) for reuses and 4 (1 – 11.5) for controls (p = 0.30). Only 6/89 re-uses (6.7%) were cited in a policy source. Conclusions Using all available re-uses of RCT data to date from major data repositories, we were not able to demonstrate that re-uses attracted more attention than a matched sample of studies published in the same journals. Small average differences are still possible, as the sample size was limited. However matching choices have some limitations so results should be interpreted very cautiously. Also, citations by policy sources for re-uses were rare. Trial registration Registration: osf.io/fp62e
first_indexed 2024-12-20T04:40:08Z
format Article
id doaj.art-ceec97086b09419c834db5a142a7848e
institution Directory Open Access Journal
issn 1471-2288
language English
last_indexed 2024-12-20T04:40:08Z
publishDate 2021-06-01
publisher BMC
record_format Article
series BMC Medical Research Methodology
spelling doaj.art-ceec97086b09419c834db5a142a7848e2022-12-21T19:53:09ZengBMCBMC Medical Research Methodology1471-22882021-06-0121111310.1186/s12874-021-01311-zSocial media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journalsN. Anthony0C. Pellen1C. Ohmann2D. Moher3F. Naudet4University Hospital of La RéunionUniv Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d’Investigation Clinique de Rennes)]European Clinical Research Infrastructure NetworkOttawa Hospital Research InstituteUniv Rennes, CHU Rennes, Inserm, CIC 1414 [(Centre d’Investigation Clinique de Rennes)]Abstract Background Data-sharing policies in randomized clinical trials (RCTs) should have an evaluation component. The main objective of this case–control study was to assess the impact of published re-uses of RCT data in terms of media attention (Altmetric) and citation rates. Methods Re-uses of RCT data published up to December 2019 (cases) were searched for by two reviewers on 3 repositories (CSDR, YODA project, and Vivli) and matched to control papers published in the same journal. The Altmetric Attention Score (primary outcome), components of this score (e.g. mention of policy sources, media attention) and the total number of citations were compared between these two groups. Results 89 re-uses were identified: 48 (53.9%) secondary analyses, 34 (38.2%) meta-analyses, 4 (4.5%) methodological analyses and 3 (3.4%) re-analyses. The median (interquartile range) Altmetric Attention Scores were 5.9 (1.3—22.2) for re-use and 2.8 (0.3—12.3) for controls (p = 0.14). No statistical difference was found on any of the components of in the Altmetric Attention Score. The median (interquartile range) numbers of citations were 3 (1—8) for reuses and 4 (1 – 11.5) for controls (p = 0.30). Only 6/89 re-uses (6.7%) were cited in a policy source. Conclusions Using all available re-uses of RCT data to date from major data repositories, we were not able to demonstrate that re-uses attracted more attention than a matched sample of studies published in the same journals. Small average differences are still possible, as the sample size was limited. However matching choices have some limitations so results should be interpreted very cautiously. Also, citations by policy sources for re-uses were rare. Trial registration Registration: osf.io/fp62ehttps://doi.org/10.1186/s12874-021-01311-zData-sharingData reuseAltmetricIndividual Participant DataClinical trialScientific transparency
spellingShingle N. Anthony
C. Pellen
C. Ohmann
D. Moher
F. Naudet
Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
BMC Medical Research Methodology
Data-sharing
Data reuse
Altmetric
Individual Participant Data
Clinical trial
Scientific transparency
title Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
title_full Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
title_fullStr Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
title_full_unstemmed Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
title_short Social media attention and citations of published outputs from re-use of clinical trial data: a matched comparison with articles published in the same journals
title_sort social media attention and citations of published outputs from re use of clinical trial data a matched comparison with articles published in the same journals
topic Data-sharing
Data reuse
Altmetric
Individual Participant Data
Clinical trial
Scientific transparency
url https://doi.org/10.1186/s12874-021-01311-z
work_keys_str_mv AT nanthony socialmediaattentionandcitationsofpublishedoutputsfromreuseofclinicaltrialdataamatchedcomparisonwitharticlespublishedinthesamejournals
AT cpellen socialmediaattentionandcitationsofpublishedoutputsfromreuseofclinicaltrialdataamatchedcomparisonwitharticlespublishedinthesamejournals
AT cohmann socialmediaattentionandcitationsofpublishedoutputsfromreuseofclinicaltrialdataamatchedcomparisonwitharticlespublishedinthesamejournals
AT dmoher socialmediaattentionandcitationsofpublishedoutputsfromreuseofclinicaltrialdataamatchedcomparisonwitharticlespublishedinthesamejournals
AT fnaudet socialmediaattentionandcitationsofpublishedoutputsfromreuseofclinicaltrialdataamatchedcomparisonwitharticlespublishedinthesamejournals